217 results
8-K
EX-10.2
ARTH
Arch Therapeutics, Inc.
21 May 24
Entry into a Material Definitive Agreement
4:30pm
be) to an independent, reputable investment bank selected by the Borrower and approved by the Lead Investor or (b) the disputed arithmetic calculation … of the Conversion Price, Conversion Amount, any prepayment amount or Default Amount, to an independent, outside accountant selected by the Lead Investor
8-K
EX-10.3
ARTH
Arch Therapeutics, Inc.
21 May 24
Entry into a Material Definitive Agreement
4:30pm
by reference) will be subject to the review of such Holders, and (ii) cause its officers and directors, counsel and independent registered public … and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings required to be made with any
8-K
EX-10.1
ARTH
Arch Therapeutics, Inc.
21 May 24
Entry into a Material Definitive Agreement
4:30pm
further represents to each Buyer that the Company’s decision to enter into this Agreement has been based solely on the independent evaluation
8-K
EX-4.1
ARTH
Arch Therapeutics, Inc.
18 Mar 24
Entry into a Material Definitive Agreement
4:29pm
) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers
8-K
EX-10.2
x1b2xh2s2yh1o6
18 Mar 24
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-10.3
n79nh9x1lrptfy
18 Mar 24
Entry into a Material Definitive Agreement
4:29pm
8-K
fl22ynoordtc0k
12 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
EX-16.1
5m48wba0g7
12 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
NT 10-K
1crpryu
29 Dec 23
Notice of late annual filing
4:30pm